Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Other solid neoplasm 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Neoplasms 10Breast Neoplasms 6Recurrence 4Lymphoma, Non-Hodgkin 4Leukemia, Myeloid, Acute 4Hematologic Neoplasms 4Wilms Tumor 3Solid Tumor 3Neuroblastoma 3Neoplasm Metastasis 3Multiple Myeloma 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, Follicular 3Lymphoma 3Leukemia, Lymphocytic, Chronic, B-Cell 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Basal Cell 3Testicular Neoplasms 2Skin Neoplasms 2Sezary Syndrome 2Prostatic Neoplasms 2Primary Myelofibrosis 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neutropenia 2Mycosis Fungoides 2Mycoses 2Medical Oncology 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Immunoblastic 2

Interventions

Granulocyte Colony-Stimulating Factor 7Filgrastim 7Etoposide 7Temozolomide 6Cyclophosphamide 6Carboplatin 6Vincristine 5Methotrexate 4Cisplatin 4tazemetostat 3etoposide phosphate 3Thiotepa 3Stem Cell Transplantation 3Peripheral Blood Stem Cell Transplantation 3Leucovorin 3ribociclib 2abemaciclib 2Vorinostat 2Sirolimus 2Radiotherapy 2Melphalan 2Irinotecan 2Busulfan 2veliparib 1trametinib 1sonidegib 1sargramostim 1reolysin 1pegylated granulocyte colony-stimulating factor 1palbociclib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Rhabdoid Tumor × Itraconazole × Clear all
NCT04537715 2025-02-19

Effects of Itraconazole and Rifampin on the Blood Tazemetostat Levels

Ipsen

Phase 1 Completed
42 enrolled 39 charts
LymphoidOther hematologic neoplasmOther solid neoplasmSarcomaThoracic

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Mesothelioma, Sarcoma, Sarcoma, Synovial, Lymphoma, Large B-Cell, Diffuse, Rhabdoid Tumor, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡